Medications for Thyroid Diseases
9 results
Cabometyx (cabozantinib)
(cabozantinib)Exelixis, Inc.
Usage: CABOMETYX is indicated for advanced renal cell carcinoma (RCC), in combination with nivolumab for first-line treatment; hepatocellular carcinoma (HCC) after sorafenib; differentiated thyroid cancer (DTC) in patients aged 12 and older with prior VEGFR therapy failure; and well-differentiated neuroendocrine tumors (pNET and epNET) in patients aged 12 and older.
Gavreto (pralsetinib)
(Pralsetinib)Genentech, Inc.
Usage: GAVRETO is indicated for treating adults with metastatic RET fusion-positive non-small cell lung cancer and for adults and pediatric patients aged 12 and older with advanced or metastatic RET fusion-positive thyroid cancer requiring systemic therapy and who are radioactive iodine-refractory.
Lenvima (lenvatinib)
(Lenvatinib)Eisai Inc.
Usage: LENVIMA is indicated for adult patients with radioactive iodine-refractory differentiated thyroid cancer, advanced renal cell carcinoma (both as first-line and following prior anti-angiogenic therapy), unresectable hepatocellular carcinoma, and advanced endometrial carcinoma that is mismatch repair proficient or not microsatellite instability-high.
Levothyroxine sodium (levothyroxine sodium)
(Levothyroxine Sodium)A-S Medication Solutions
Usage: Levothyroxine sodium tablets are indicated for replacement therapy in primary, secondary, and tertiary hypothyroidism in adults and children, including neonates. They are also used as an adjunct in managing thyrotropin-dependent well-differentiated thyroid cancer. It is not recommended for benign thyroid nodules or during subacute thyroiditis recovery.
Sodium iodide i 131 diagnostic (sodium iodide i 131)
(Sodium Iodide I 131)Jubilant DraxImage Inc., dba Jubilant Radiopharma
Usage: Sodium Iodide I 131 Capsules Diagnostic are indicated for adults to assess thyroid function through radioactive iodine uptake tests and for imaging the thyroid via scintigraphy.
Symbio asper drops (aspergillus niger)
(Aspergillus niger)Symbiopathic
Usage: This drug is indicated for treating symptoms related to allergies, rheumatic illnesses, stomach ulcers, hyperactive thyroid, lymphatic issues, and phthisis, based on traditional homeopathic practices.
Tafinlar (dabrafenib)
(dabrafenib)Novartis Pharmaceuticals Corporation
Usage: TAFINLAR is indicated for treating unresectable or metastatic melanoma with BRAF V600E/K mutations, as well as for adjuvant treatment post-resection. It is also used for metastatic non-small cell lung cancer, anaplastic thyroid cancer, unresectable solid tumors, and low-grade glioma in pediatric patients, all with the BRAF V600E mutation.
Thyreoidea compositum (lactic acid, l- and viscum album and colchicum autumnale bulb and conium maculatum flowering top and galium aparine and fucus vesiculosus and sedum acre and sempervivum tectorum leaf and adenosine triphosphate and fumaric acid and alpha-ketoglutaric acid and malic acid and sodium diethyloxalacetate and pulsatilla vulgaris and spongia officinalis skeleton, roasted and sus scrofa thyroid and calcium fluoride and sus scrofa umbilical cord and pork liver and sus scrofa bone marrow and sus scrofa spleen )
(LACTIC ACID, L- and VISCUM ALBUM and COLCHICUM AUTUMNALE BULB and CONIUM MACULATUM FLOWERING TOP and GALIUM APARINE and FUCUS VESICULOSUS and SEDUM ACRE and SEMPERVIVUM TECTORUM LEAF and ADENOSINE TRIPHOSPHATE and FUMARIC ACID and ALPHA-KETOGLUTARIC ACID and MALIC ACID and SODIUM DIETHYLOXALACETATE and PULSATILLA VULGARIS and SPONGIA OFFICINALIS SKELETON, ROASTED and SUS SCROFA THYROID and CALCIUM FLUORIDE and SUS SCROFA UMBILICAL CORD and PORK LIVER and SUS SCROFA BONE MARROW and SUS SCROFA SPLEEN)Heel Inc
Usage: Thyreoidea compositum® Injection Solution is indicated for stimulating the immune system in cases of thyroid dysfunction, connective tissue dysfunction, and glandular dysfunction.
Thyrotropin releasing hormone (thyrotropin releasing hormone)
(Thyrotropin Releasing Hormone)AnazaoHealth Corporation
Usage: TRH is indicated for diagnosing thyroid function, assessing pituitary or hypothalamic dysfunction, evaluating thyrotropin suppression in goiter patients, and adjusting thyroid hormone dosage in primary hypothyroidism to ensure adequate replacement therapy.